Paper25453091
(+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium.
Jiménez-Díaz MB and 49 others. Proc Natl Acad Sci U S A, 2014. Cited by 199 papers, by iCite.
Cite this record
ConductScience Library. (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium. Papers, record 25453091. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25453091
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimalarials | Major topic |
| Calcium-Transporting ATPases | Major topic |
| Heterocyclic Compounds, 4 or More Rings | Major topic |
| Isoquinolines | Major topic |
| Malaria | Major topic |
| Models, Molecular | Major topic |
| Plasmodium | Major topic |
| Cellular Senescence | |
| Drug Discovery | |
| Drug Resistance | |
| Erythrocytes | |
| Flow Cytometry | |
| High-Throughput Screening Assays | |
| Molecular Structure |
Source PubMed
Grants11
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01 AI075517 | NIAID NIH HHS | United States | U01AI075517 | PubMed and NIH | NIH RePORTER |
| T32 GM067547 | NIGMS NIH HHS | United States | T32GM067547 | PubMed and NIH | NIH RePORTER |
| T32 EB009383 | NIBIB NIH HHS | United States | T32EB009383 | PubMed and NIH | NIH RePORTER |
| HHSN272201100022C | NIAID NIH HHS | United States | PubMed | PubMed | |
| AI075517 | NIAID NIH HHS | United States | U01AI075517 | PubMed and NIH | NIH RePORTER |
| HHSN2722011000221 | PHS HHS | United States | PubMed | PubMed | |
| P30 CA021765 | NCI NIH HHS | United States | P30CA021765 | PubMed and NIH | NIH RePORTER |
| Howard Hughes Medical Institute | United States | PubMed | PubMed | ||
| AI090662 | NIAID NIH HHS | United States | R01AI090662 | PubMed and NIH | NIH RePORTER |
| HHSN272201100022I | NIAID NIH HHS | United States | PubMed | PubMed | |
| R01 AI090662 | NIAID NIH HHS | United States | R01AI090662 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04709692 | Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria | Background |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 26430239 | Correction for Jiménez-Díaz et al., (+)-SJ733, a clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium. | https://conductscience.org/library/papers/26430239 |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16775118 | Assessment of erythrocyte shape by flow cytometry techniques. | J Clin Pathol | 2007 | https://conductscience.org/library/papers/16775118 | PubMed |
| 2 | 23742293 | Designing the next generation of medicines for malaria control and eradication. | Malar J | 2013 | https://conductscience.org/library/papers/23742293 | PubMed |
| 3 | 23798988 | The open access malaria box: a drug discovery catalyst for neglected diseases. | PLoS One | 2013 | https://conductscience.org/library/papers/23798988 | PubMed |
| 4 | 19267900 | CNV-seq, a new method to detect copy number variation using high-throughput sequencing. | BMC Bioinformatics | 2009 | https://conductscience.org/library/papers/19267900 | PubMed |
| 5 | 1503432 | Molecular targets of 5-fluoroorotate in the human malaria parasite, Plasmodium falciparum. | Antimicrob Agents Chemother | 1992 | https://conductscience.org/library/papers/1503432 | PubMed |
| 6 | 20813948 | Spiroindolones, a potent compound class for the treatment of malaria. | Science | 2010 | https://conductscience.org/library/papers/20813948 | PubMed |
| 7 | 4008648 | Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. | J Clin Invest | 1985 | https://conductscience.org/library/papers/4008648 | PubMed |
| 8 | 19596869 | Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19596869 | PubMed |
| 9 | 24523696 | Of macrophages and red blood cells; a complex love story. | Front Physiol | 2014 | https://conductscience.org/library/papers/24523696 | PubMed |
| 10 | 22958514 | The global pipeline of new medicines for the control and elimination of malaria. | Malar J | 2012 | https://conductscience.org/library/papers/22958514 | PubMed |
| 11 | 6546931 | Adhesivity and rigidity of erythrocyte membrane in relation to wheat germ agglutinin binding. | J Cell Biol | 1984 | https://conductscience.org/library/papers/6546931 | PubMed |
| 12 | 3988747 | In vivo recognition and clearance of red blood cells containing phosphatidylserine in their plasma membranes. | J Biol Chem | 1985 | https://conductscience.org/library/papers/3988747 | PubMed |
| 13 | 19710527 | Suicide for survival--death of infected erythrocytes as a host mechanism to survive malaria. | Cell Physiol Biochem | 2009 | https://conductscience.org/library/papers/19710527 | PubMed |
| 14 | 22242845 | Back to the future: lessons learned in modern target-based and whole-cell lead optimization of antimalarials. | Curr Top Med Chem | 2012 | https://conductscience.org/library/papers/22242845 | PubMed |
| 15 | 25075833 | Spiroindolone KAE609 for falciparum and vivax malaria. | N Engl J Med | 2014 | https://conductscience.org/library/papers/25075833 | PubMed |
| 16 | 22318405 | Microfluidic biomechanical assay for red blood cells parasitized by Plasmodium falciparum. | Lab Chip | 2012 | https://conductscience.org/library/papers/22318405 | PubMed |
| 17 | 23414762 | Na(+) regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials. | Cell Host Microbe | 2013 | https://conductscience.org/library/papers/23414762 | PubMed |
| 18 | 3044154 | X-ray microanalysis of Plasmodium falciparum and infected red blood cells: effects of qinghaosu and chloroquine on potassium, sodium, and phosphorus composition. | Am J Trop Med Hyg | 1988 | https://conductscience.org/library/papers/3044154 | PubMed |
| 19 | 21427291 | Mechanism for phosphatidylserine-dependent erythrophagocytosis in mouse liver. | Blood | 2011 | https://conductscience.org/library/papers/21427291 | PubMed |
| 20 | 23715326 | Genome sequencing sheds light on emerging drug resistance in malaria parasites. | Nat Genet | 2013 | https://conductscience.org/library/papers/23715326 | PubMed |
Cited by139
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 199 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42006802 | Mechanistic perspectives on antimalarial agents: from FDA-approved drugs to next-generation candidates. | RSC Adv | 2026 | https://conductscience.org/library/papers/42006802 | PubMed |
| 41980931 | Potent acridone antimalarial against all three life stages of Plasmodium. | Nat Commun | 2026 | https://conductscience.org/library/papers/41980931 | PubMed |
| 41484625 | Natural triterpenic phenolic esters target PfA-M17 in Plasmodium falciparum. | Malar J | 2026 | https://conductscience.org/library/papers/41484625 | PubMed |
| 41441052 | Impacts of Cipargamin on Na+-ATPase and Osmoregulation of Trypanosoma cruzi. | Membranes (Basel) | 2025 | https://conductscience.org/library/papers/41441052 | PubMed |
| 41178292 | The impact of phenotypic- versus target-based approaches in antimalarial drug discovery in the last two decades (2005-2025). | Future Med Chem | 2025 | https://conductscience.org/library/papers/41178292 | PubMed |
| 41144577 | PfATP2 is a flippase on the Plasmodium falciparum surface that is important for growth and influences parasite sensitivity to antiplasmodial compounds. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/41144577 | PubMed |
| 41115914 | Endogenous structure of antimalarial target PfATP4 reveals an apicomplexan-specific P-type ATPase modulator. | Nat Commun | 2025 | https://conductscience.org/library/papers/41115914 | PubMed |
| 41002306 | Pathophysiological Associations and Measurement Techniques of Red Blood Cell Deformability. | Biosensors (Basel) | 2025 | https://conductscience.org/library/papers/41002306 | PubMed |
| 40921413 | Identification of α-Azacyclic Acetamide-Based Inhibitors of P. falciparum Na+ Pump (PfATP4) with Fast-Killing Asexual Blood-Stage Antimalarial Activity by Phenotypic Screening. | ACS Infect Dis | 2025 | https://conductscience.org/library/papers/40921413 | PubMed |
| 40921080 | Structure-Activity Relationships of 3-Hydroxypropanamidines (HPAs) with Potent In Vivo Antimalarial Activity. | J Med Chem | 2025 | https://conductscience.org/library/papers/40921080 | PubMed |
| 40715087 | An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs. | Nat Commun | 2025 | https://conductscience.org/library/papers/40715087 | PubMed |
| 40523953 | Malaria: past, present, and future. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40523953 | PubMed |
| 40228810 | Optimization and Characterization of N-Acetamide Indoles as Antimalarials That Target PfATP4. | J Med Chem | 2025 | https://conductscience.org/library/papers/40228810 | PubMed |
| 39773028 | Mutational analysis of an antimalarial drug target, PfATP4. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/39773028 | PubMed |
| 39738025 | Genome sequencing of Plasmodium malariae identifies continental segregation and mutations associated with reduced pyrimethamine susceptibility. | Nat Commun | 2024 | https://conductscience.org/library/papers/39738025 | PubMed |
| 39723908 | TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial In Vivo Activity and a High Barrier to Resistance. | J Med Chem | 2025 | https://conductscience.org/library/papers/39723908 | PubMed |
| 39607932 | Systematic in vitro evolution in Plasmodium falciparum reveals key determinants of drug resistance. | Science | 2024 | https://conductscience.org/library/papers/39607932 | PubMed |
| 39548094 | Eliminating malaria transmission requires targeting immature and mature gametocytes through lipoidal uptake of antimalarials. | Nat Commun | 2024 | https://conductscience.org/library/papers/39548094 | PubMed |
| 39264187 | An adaptable, fit-for-purpose screening approach with high-throughput capability to determine speed of action and stage specificity of anti-malarial compounds. | Antimicrob Agents Chemother | 2024 | https://conductscience.org/library/papers/39264187 | PubMed |
| 39210733 | Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4. | ChemMedChem | 2024 | https://conductscience.org/library/papers/39210733 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| DNAH8 | 1769 | PubTator's text mining | https://conductscience.org/library/genes/1769 |
Source NCBI Gene
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| BioProject | PRJNA253899 |
Source BioProject
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25453091
GET https://conductscience.org/api/papers/v1/25453091/authors?page=2